Can a common gout pill protect the heart and lungs during surgery?

NCT ID NCT06118034

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the anti-inflammatory drug colchicine can reduce organ damage after heart surgery. About 768 adults aged 50-80 having planned heart surgery will take either colchicine or a placebo before and after their operation. Researchers will track complications like atrial fibrillation, heart attack, and lung injury.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

colchicine

What this could lead to

If it works, this could reduce serious complications like atrial fibrillation, heart attack, and lung injury after heart surgery.

What could go wrong

This is a phase 3 trial, but colchicine may cause gastrointestinal side effects and may not reduce complications as hoped. Results may not apply to all heart surgery patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dong-Jin Wang

    RECRUITING

    Nanjing, Jiangsu, 210008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••